Transcriptomics

Dataset Information

0

Tet1 plays an essential oncogenic role in MLL-rearranged leukemia


ABSTRACT: TET1, the founding member of the TET family of enzymes (TET1/2/3) that convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), was first identified as a partner gene in MLL-rearranged leukemia, but its definitive pathological role in leukemia is unclear. The down-regulation of all three TET genes and loss-of-function mutations of TET2 have been frequently observed in various cancers, and it was thought that they all play tumor-suppressor roles in tumorigenesis. Here we show that TET1 is likely a direct target of MLL and significantly up-regulated in MLL-rearranged leukemia, associated with an increased level of 5hmC. Our further in vitro and in vivo studies demonstrate that Tet1 plays an indispensable oncogenic role in MLL-rearranged leukemia, through cooperating with MLL fusion proteins in regulating their co-targets including the Hoxa/Meis1/Pbx3/Flt3 genes. Our data delineate a MLL-fusion/Tet1/Hoxa/Meis1/Pbx3/Flt3 signaling axis in MLL-rearranged leukemia, and highlight TET1 as a potential therapeutic target in treating this presently therapy-resistant disease.

ORGANISM(S): Mus musculus

PROVIDER: GSE42990 | GEO | 2015/12/14

SECONDARY ACCESSION(S): PRJNA184036

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-12-14 | E-GEOD-42990 | biostudies-arrayexpress
2009-01-26 | E-GEOD-13714 | biostudies-arrayexpress
2009-01-01 | GSE13714 | GEO
2016-03-03 | GSE68643 | GEO
2014-11-11 | GSE55287 | GEO
2014-11-11 | GSE55713 | GEO
2019-07-03 | E-MTAB-7356 | biostudies-arrayexpress
2021-07-15 | GSE162441 | GEO
2020-07-01 | GSE144759 | GEO
2008-12-23 | GSE14101 | GEO